Location: Seattle, WA

The study's objective is to explore the safety and tolerability of STX209 in subjects with Autism Spectrum Disorders and to obtain preliminary data on several measures of efficacy in treating irritability.

Location: Boston, MA

In this study we are using functional magnetic resonance imaging (fMRI) to investigate the neurological basis of decreased eye contact and gaze following in males with autism aged 14-40. 

Location: Nashville, TN

The study objective is to explore the safety and tolerability of STX209 in subjects with Autism Spectrum Disorders and to obtain preliminary data on several measures of efficacy in treating irritability.

Location: Falls Church, VA

The purpose of this survey is to: 1) provide better understanding of the prevalence of feeding problems among children with ASD between the ages of 3 and 12, and to compare them to age-matched siblings; 2) estimate the prevalence of organic and functional gastrointestinal problems among children with ASD and their siblings. The study will add to the existing knowledge on this subject and will help physicians and other professionals provide better care and counseling on this subject to families of children with ASD.

Location: Miami Shores, FL
Online Survey!

This study proposes to examine parents’ perception of the link between vaccination and autism and whether it varies with regards to ethnicity, parental education and socioeconomic status. This study will also look at whether parents’ trust of health professionals and government organizations influences their behavior towards vaccinating a subsequent child.

Location: New Haven, CT

This study will examine the early development of basic social skills in young children. We will observe how children with various developmental delays and typical development look at people and perceive speech. This research will lead to the development of new methods to diagnose developmental delays in toddlers, including autism spectrum disorder (ASD).  

Location: Multiple Cities across the U.S.

Johnson & Johnson Pharmaceutical Research & Development is now conducting a study to evaluate the effectiveness, safety and tolerability of a higher and lower dose of an investigational agent in children and adolescents with autism. This agent is approved for use at the higher does. Johnson & Johnson seeks to determine if a lower dose is also effective.  

Location: Nashville, TN

This study is designed to gather information about the perceptions and experiences of parents and caregivers, with a specific interest in their levels of satisfaction with regards to their child's pediatrician.  This study will make it possible to define the factors that are associated with increased satisfaction with pediatricians and identify regional differences in knowledge, actions, care or support by pediatricians.  

Location: Staten Island, NY

The purpose of this study is to develop and test an assessment instrument that can be used to identify and to assess the progress of high-functioning children, adolescents and young adults who are on the autism spectrum.

Location: Philadelphia, PA

This is a 6-week study which investigates the use of olanzapine to decrease disruptive behaviors sometimes associated with children with autism, ages 3 to 12 years old. The study is double-blind and placebo controlled, meaning that patients receive either placebo or olanzapine, and that neither the researchers nor the patients know whether or not they are receiving placebo or olanzapine.

Location: Chapel Hill, NC

This study will look at the genetics of autism by examining 12 extended families with more than one family branch containing a member of the family with autism, Asperger’s or Pervasive Developmental Disorder (PDD) ascertained by assessment and medical records.

Location:  Multiple study locations can be found at : www.AutismClinicalTrial.org

CN138-178: This study will compare the effectiveness (how well the drug works) of aripiprazole, flexibly dosed with a placebo, in reducing serious behavioral problems in children and adolescents with a diagnosis of autistic disorder (AD).

CN138-179: This study will compare the effectiveness (how well the drug works) of aripiprazole with placebo (fixed dose) in reducing serious behavioral problems in children and adolescents with a diagnosis of autistic disorder (AD).

Location: Indianapolis, IN

The purpose of this study is to find out if oral N-acetylcysteine is helpful for improving some of the behavioral symptoms associated with autism spectrum disorders. This study will evaluate the safety and effectiveness of oral N-acetylcysteine in children with an autism spectrum disorder. N-acetylcysteine is currently used to treat acetaminophen overdose and certain lung conditions. This medication has not been approved by the FDA for the treatment of Autism Spectrum Disorders.

Location: New Haven, CT

This project is designed to examine sensitivity to facial information about speech and language in children with ASD. This application uses visual tracking methodology to evaluate the degree to which children with ASD use facial speech information in clear and noisy listening conditions.

Location:  New York, NY

The goal of this study is to find out which genes (material inherited from ones parents) play a role in developmental delay or autism spectrum disorders and how these disorders run in families.

Location:  Baltimore, MD

This is a pilot project that will collect information and biologic samples from mothers of children with an autism spectrum disorder (ASD) during the course of a subsequent pregnancy.   By doing this we hope to learn how to best to collect and analyze this type of data so that we can successfully implement a larger study in the future.  This large study would address the question of whether exposures or biomarkers measured during pregnancy or very early in life increase the risk of a sibling of a child with ASD themselves developing an ASD.